HLA-DR Antikörper (FITC)
-
- Target Alle HLA-DR Produkte
- HLA-DR
-
Reaktivität
- Human
-
Wirt
- Ratte
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLA-DR Antikörper ist konjugiert mit FITC
-
Applikation
- Flow Cytometry (FACS), Immunofluorescence (IF)
- Spezifität
- HLA-DR Ia chain Cross reactive with mouse H-2, I-A subregion
- Aufreinigung
- Purified from ascites via Protein G Chromatography
- Immunogen
- EHR-B Ramos cells . Fusion Partner: Y3 Ag1.2.3 rat myeloma . Donor: immunized AO rat spleen cells
- Isotyp
- IgG2a
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- 0.1 mg/ml
- Buffer
- FITC conjugated Ig buffered in PBS, 0.02% NaN and EIA grade BSA as a stabilizing protein to bring total protein concentration to 4-5 mg/ml.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
-
- Target
- HLA-DR
- Andere Bezeichnung
- HLA-DR (HLA-DR Produkte)
- Hintergrund
- FITC anti-human HLA-DR monoclonal antibody recognizes an epitope on the Ia chain of the Human lymphocyte antigen. This antibody has also been shown to recognize the H-2, I-A region of the mouse.
-